Nuzenio

Tipranks Exelixis

Tipranks Exelixis entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 00:24:20 GMTExelixis Earnings Call: Cabo Strength, Zanza Awaited - TipRanks

Fri, 07 Aug 2026 00:44:18 GMTExelixis price target lowered to $52 from $56 at Truist - TipRanks

Thu, 06 Aug 2026 18:34:16 GMTExelixis Targets Residual Colorectal Cancer With New Phase 3 Trial - TipRanks

Thu, 06 Aug 2026 10:36:07 GMTExelixis: Buy Rating Reaffirmed on Cabozantinib Resilience, Cost Discipline and Zanzalintinib Upside Despite Near-Term NET Guidance Cut - TipRanks

Thu, 06 Aug 2026 07:00:00 GMTExelixis price target raised to $51 from $47 at Stifel - TipRanks

Fri, 31 Jul 2026 01:40:35 GMTExelixis (EX9) Q3 2023 Earnings Report - Results, Call & Slides - TipRanks

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Call7 live mentions Exelixis6 live mentions Earnings Report6 live mentions Results6 live mentions Slides3 live mentions Slides TipRanks TipRanks3 live mentions Cabo Strength2 live mentions Buy Rating Reaffirmed2 live mentions Cabozantinib Resilience2 live mentions Cost Discipline2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Exelixis.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.